OncoGenomics Unveils Nigeria’s First In-Country Paternity Testing Facility
OncoGenomics, a leading diagnostic firm in Nigeria, announced the introduction of the country’s first in-country paternity testing program on Friday. This ground-breaking project intends to drastically reduce Nigerians’ reliance on abroad facilities for paternity testing, which has traditionally been both time-consuming and costly. The new diagnostic service, which uses Next Generation Sequencing (NGS) technology, promises results with a probability of paternity surpassing 99.999%, meeting international gold standards for accuracy and dependability. A New Era of Genetic Testing in Nigeria During the facility’s unveiling in Lagos, Dr. Paul Faduola, the founder of OncoGenomics, described NGS technology adoption as a transformative milestone for the country’s healthcare industry. “NGS is the epitome of precision, reliability, and innovation. “We are creating a future in which every Nigerian […]





